Blog
Lexicon Pharmaceuticals Q1 Earnings Call Highlights
Lexicon Pharmaceuticals (NASDAQ:LXRX) executives highlighted progress across late-stage regulatory programs and efforts to bolster the company’s financial position during the company’s
Liquidity Services Q2 Earnings Call Highlights
Liquidity Services (NASDAQ:LQDT) reported fiscal second-quarter 2026 results that management said reflected market share gains and improved operating leverage despite what CEO Bill Angrick
NewAmsterdam Pharma Sets PREVAIL Interim Analysis for Q4 2026 on Encouraging Blinded Trends
NewAmsterdam Pharma (NASDAQ:NAMS) said it plans to conduct an interim analysis of its ongoing PREVAIL cardiovascular outcomes trial (CVOT) for obicetrapib in the fourth quarter of 2026, citing what
El Pollo Loco Q1 Earnings Call Highlights
El Pollo Loco (NASDAQ:LOCO) reported first-quarter 2026 results that management said reflected continued momentum from its ongoing brand transformation
Open Lending Q1 Earnings Call Highlights
Open Lending (NASDAQ:LPRO) reported first-quarter 2026 results that management said reflected continued operational discipline amid a
LightPath Technologies Q3 Earnings Call Highlights
LightPath Technologies (NASDAQ:LPTH) reported fiscal third-quarter 2026 results on May 7, highlighting what management described as continued
Lantheus Q1 Earnings Call Highlights
Lantheus (NASDAQ:LNTH) reported what management described as a strong start to 2026, citing solid performance from its three core
Liberty Latin America Q1 Earnings Call Highlights
Liberty Latin America (NASDAQ:LILA) executives told investors the company opened 2026 with what CEO Balan Nair described as a “very solid performance,” highlighted by mobile postpaid subscriber
LifeStance Health Group Q1 Earnings Call Highlights
LifeStance Health Group (NASDAQ:LFST) reported first-quarter 2026 results that management said exceeded expectations and prompted the company to raise full-year guidance across its key metrics. On
Ligand Pharmaceuticals Q1 Earnings Call Highlights
Ligand Pharmaceuticals (NASDAQ:LGND) reported first-quarter 2026 results that management said reflect the operating leverage of its royalty aggregation strategy, highlighted by growing royalties
Lifetime Brands Q1 Earnings Call Highlights
Lifetime Brands (NASDAQ:LCUT) reported first-quarter 2026 results that management said extended momentum from late 2025, with year-over-year growth in net sales and adjusted profitability as
Morningstar Shareholders Approve All AGM Proposals, Back Directors, Pay Vote and KPMG Auditor
Morningstar (NASDAQ:MORN) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of 10
Lamar Advertising Q1 Earnings Call Highlights
Lamar Advertising (NASDAQ:LAMR) reported first-quarter 2026 results that exceeded internal expectations on both revenue and profitability, supported by strength in local advertising and a notable
Karat Packaging Q1 Earnings Call Highlights
Karat Packaging (NASDAQ:KRT) reported a “robust” start to fiscal 2026, with first-quarter sales up nearly 13% year over year amid improving
nLight Q1 Earnings Call Highlights
nLight (NASDAQ:LASR) reported what management called an “exceptional” first quarter of 2026, with revenue, margins, and profitability coming in
Joint Q1 Earnings Call Highlights
The Joint (NASDAQ:JYNT) reported first-quarter 2026 results that management said reflect improving profitability as the company nears completion of its “Joint 2.0” transformation into a “pure-play
Kulicke and Soffa Industries Q2 Earnings Call Highlights
Kulicke and Soffa Industries (NASDAQ:KLIC) reported fiscal second-quarter 2026 results that management said reflected faster-than-expected
Ispire Technology Q3 Earnings Call Highlights
Ispire Technology (NASDAQ:ISPR) executives told investors the company’s fiscal third quarter of 2026 marked a “turning point,” citing tighter operating discipline, early signs of liquidity
Kodiak AI Q1 Earnings Call Highlights
Kodiak AI (NASDAQ:KDK) executives used the company’s first-quarter fiscal 2026 earnings call to highlight a $100 million capital raise, progress scaling paid driverless operations, and new
Ironwood Pharmaceuticals Q1 Earnings Call Highlights
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported a strong start to 2026 and reiterated its full-year outlook, pointing to sharp first-quarter
Is Backblaze the Next Momentum Monster?
A staggering 64% single-day stock appreciation on more than 30 times the average trading volume is rarely a quiet event. For storage cloud platform Backblaze, Inc. (NASDAQ: BLZE), the explosive
The AI Fear Around Datadog Stock May Have Been Completely Wrong
Datadog (NASDAQ: DDOG) is a great example of why investing based on emotion, contrary to fundamentals, is such a bad idea. Fear of a Software-as-a-Service (SaaS) AI disruption helped to drive
3 REITs to Watch as AI Data Center Spending Surpasses Office Construction
The proliferation of artificial intelligence (AI) has resulted in abundant market opportunities.
From NVIDIA (NASDAQ: NVDA) to Micron Technology (NASDAQ: MU), AI stocks have shown their ability to
IonQ Just Posted a Breakout Quarter—But 1 Problem Remains
Quantum computing leader IonQ Inc. (NYSE: IONQ) was among the first pure-play quantum firms to report Q1 2026 earnings, and better-than-expected results on multiple fronts helped to propel shares
Uber's Annual Product Showcase Reveals It Is Coming for Airbnb and Booking
uber
Since its public debut in May 2019, Uber Technologies (NYSE: UBER) has seen its fair share of ups and downs. But since hitting its five-year low in June 2022, the stock has provided

